Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline Open-Label Extension in Advanced PD
NCT00203164Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- May 2002
- Primary completion
- Jul 2005
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of rasagiline in Parkinson's disease (PD), sponsored by Teva Pharmaceutical Industries Ltd.. Started May 2002; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00203164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203164.